These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9388240)

  • 1. Systematic exploration of the antigen binding activity of synthetic peptides isolated from the variable regions of immunoglobulins.
    Laune D; Molina F; Ferrieres G; Mani JC; Cohen P; Simon D; Bernardi T; Piechaczyk M; Pau B; Granier C
    J Biol Chem; 1997 Dec; 272(49):30937-44. PubMed ID: 9388240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-dimensional structures of the free and antigen-bound Fab from monoclonal antilysozyme antibody HyHEL-63(,).
    Li Y; Li H; Smith-Gill SJ; Mariuzza RA
    Biochemistry; 2000 May; 39(21):6296-309. PubMed ID: 10828942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide models of immunological recognition: paratope dissection by multiple peptide synthesis.
    Laune D; Pau B; Granier C
    Clin Chem Lab Med; 1998 Jun; 36(6):367-71. PubMed ID: 9711423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of anti-Hen egg white lysozyme antibody (HyHEL-10) Fv-antigen complex. Local structural changes in the protein antigen and water-mediated interactions of Fv-antigen and light chain-heavy chain interfaces.
    Kondo H; Shiroishi M; Matsushima M; Tsumoto K; Kumagai I
    J Biol Chem; 1999 Sep; 274(39):27623-31. PubMed ID: 10488102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissection of binding interactions in the complex between the anti-lysozyme antibody HyHEL-63 and its antigen.
    Li Y; Urrutia M; Smith-Gill SJ; Mariuzza RA
    Biochemistry; 2003 Jan; 42(1):11-22. PubMed ID: 12515535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of specificity-determining residues in antibodies.
    Padlan EA; Abergel C; Tipper JP
    FASEB J; 1995 Jan; 9(1):133-9. PubMed ID: 7821752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional mapping of conserved residues located at the VL and VH domain interface of a Fab.
    Chatellier J; Van Regenmortel MH; Vernet T; Altschuh D
    J Mol Biol; 1996 Nov; 264(1):1-6. PubMed ID: 8950262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody framework residues affecting the conformation of the hypervariable loops.
    Foote J; Winter G
    J Mol Biol; 1992 Mar; 224(2):487-99. PubMed ID: 1560463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular modeling of an anti-DNA autoantibody (V-88) and mapping of its V region epitopes recognized by heterologous and autoimmune antibodies.
    Hobby P; Ward FJ; Denbury AN; Williams DG; Staines NA; Sutton BJ
    J Immunol; 1998 Sep; 161(6):2944-52. PubMed ID: 9743357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of interface framework residues in determining antibody V(H)/V(L) interaction strength and antigen-binding affinity.
    Masuda K; Sakamoto K; Kojima M; Aburatani T; Ueda T; Ueda H
    FEBS J; 2006 May; 273(10):2184-94. PubMed ID: 16649995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of BR96 binding sites for antigen and anti-idiotype by codon-based scanning mutagenesis.
    Rosok MJ; Eghtedarzadeh-Kondri M; Young K; Bajorath J; Glaser S; Yelton D
    J Immunol; 1998 Mar; 160(5):2353-9. PubMed ID: 9498776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unraveling the effect of changes in conformation and compactness at the antibody V(L)-V(H) interface upon antigen binding.
    Pellequer JL; Chen Sw; Roberts VA; Tainer JA; Getzoff ED
    J Mol Recognit; 1999; 12(4):267-75. PubMed ID: 10440998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical contribution of VH-VL interaction to reshaping of an antibody: the case of humanization of anti-lysozyme antibody, HyHEL-10.
    Nakanishi T; Tsumoto K; Yokota A; Kondo H; Kumagai I
    Protein Sci; 2008 Feb; 17(2):261-70. PubMed ID: 18227432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptidomimics of antigen are present in variable region of heavy and light chains of anti-idiotypic antibody and function as surrogate antigen for perpetuation of immunological memory.
    Vani J; Justin J; Nagasuma RC; Nayak R; Shaila MS
    Mol Immunol; 2007 Jul; 44(13):3345-54. PubMed ID: 17408744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unusual joining sites in the H and L chains of an anti-lysozyme antibody.
    Hartman AB; Mallett CP; Sheriff S; Smith-Gill SJ
    J Immunol; 1988 Aug; 141(3):932-6. PubMed ID: 3135317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific binding of a synthetic peptide derived from an antibody complementarity determining region to phosphatidylserine.
    Igarashi K; Asai K; Kaneda M; Umeda M; Inoue K
    J Biochem; 1995 Feb; 117(2):452-7. PubMed ID: 7608138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of the VK4 light chain to antibody specificity for lysozyme and beta (1,6)D-galactan.
    Smith-Gill SJ; Hamel PA; Klein MH; Rudikoff S; Dorrington KJ
    Mol Immunol; 1986 Sep; 23(9):919-26. PubMed ID: 3097519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of the octapeptide angiotensin II with a high-affinity single-chain Fv and with peptides derived from the antibody paratope.
    Cohen P; Laune D; Teulon I; Combes T; Pugnière M; Badouaille G; Granier C; Mani JC; Simon D
    J Immunol Methods; 2001 Aug; 254(1-2):147-60. PubMed ID: 11406160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a universal VHH framework to graft non-canonical antigen-binding loops of camel single-domain antibodies.
    Saerens D; Pellis M; Loris R; Pardon E; Dumoulin M; Matagne A; Wyns L; Muyldermans S; Conrath K
    J Mol Biol; 2005 Sep; 352(3):597-607. PubMed ID: 16095608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The His-probe method: effects of histidine residues introduced into the complementarity-determining regions of antibodies on antigen-antibody interactions at different pH values.
    Ito W; Sakato N; Fujio H; Yutani K; Arata Y; Kurosawa Y
    FEBS Lett; 1992 Aug; 309(1):85-8. PubMed ID: 1511750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.